Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158002 · ClinicalTrials.gov registry record · Phase 2
A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
A Phase 2 study, sponsored by Monarch Medical Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00158002 is a Phase 2 study that has completed, run by Monarch Medical Research. The registered enrollment target is 40 participants.
The verdict
NCT00158002, a Phase 2 study, has completed, sponsored by Monarch Medical Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to assess the long-term safety and effectiveness of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158002
The ClinicalTrials.gov registry entry for NCT00158002 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monarch Medical Research, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00158002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158002 about?
NCT00158002 is a clinical study titled "A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine". The objective of this study is to assess the long-term safety and effectiveness of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
What is the current status of trial NCT00158002?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2004-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00158002?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00158002?
This trial is sponsored by Monarch Medical Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.